OptimizeRx Corporation
OPRX
$6.60
$0.172.57%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 125.52% | 100.14% | 44.91% | 14.71% | -14.48% |
| Total Depreciation and Amortization | -0.05% | 2.00% | 18.35% | 40.92% | 73.37% |
| Total Amortization of Deferred Charges | 32.93% | 27.83% | 77.49% | 103.61% | 295.73% |
| Total Other Non-Cash Items | -61.75% | -71.11% | -23.46% | -19.48% | -17.28% |
| Change in Net Operating Assets | 21.61% | 83.97% | 86.03% | 94.27% | 104.32% |
| Cash from Operations | 282.80% | 854.63% | 652.47% | 231.75% | 167.53% |
| Capital Expenditure | 48.21% | 36.00% | 37.39% | -18.89% | -28.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 137.28% | -100.36% | -100.50% | -100.48% | -100.61% |
| Cash from Investing | 115.11% | 99.02% | 98.75% | 98.41% | 98.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -100.00% | -149.22% | -195.20% | -81.00% | -133.92% |
| Issuance of Common Stock | -- | 2,153.33% | -- | -- | -- |
| Repurchase of Common Stock | -26.23% | 30.15% | 40.27% | 89.18% | 88.56% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -79.15% | -123.97% | -124.64% | -117.53% | -117.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,215.47% | -45.30% | -68.44% | 210.36% | 89.17% |